These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7473182)

  • 21. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
    Martin PL; May JM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
    De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
    Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
    J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
    Webb RL; McNeal RB; Barclay BW; Yasay GD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1090-9. PubMed ID: 2203898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling hemodynamic profiles by telemetry in the rat. A study with A1 and A2a adenosine agonists.
    Bonizzoni E; Milani S; Ongini E; Casati C; Monopoli A
    Hypertension; 1995 Apr; 25(4 Pt 1):564-9. PubMed ID: 7721399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of adenosine receptor agonists on renal function in anaesthetized rats.
    Panzacchi G; Demarchi B; Busca G; Protasoni G; Golin R; Stella A
    J Hypertens; 1997 Dec; 15(12 Pt 2):1785-9. PubMed ID: 9488240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
    Priviero F; De Nucci G; Antunes E; Zanesco A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
    Listos J; Malec D; Fidecka S
    Eur J Pharmacol; 2005 Oct; 523(1-3):71-8. PubMed ID: 16226742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
    Patel M; Sheehan MJ; Strong P
    Br J Pharmacol; 1994 Nov; 113(3):741-8. PubMed ID: 7858863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Eur J Pharmacol; 1996 Jun; 307(2):163-9. PubMed ID: 8832218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.
    Hiley CR; Bottrill FE; Warnock J; Richardson PJ
    Br J Pharmacol; 1995 Nov; 116(6):2641-6. PubMed ID: 8590983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
    Cooper JA; Hill SJ; Alexander SP; Rubin PC; Horn EH
    Br J Clin Pharmacol; 1995 Jul; 40(1):43-50. PubMed ID: 8527267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine-induced vasodilation: receptor characterization in pulmonary circulation.
    Haynes J; Obiako B; Thompson WJ; Downey J
    Am J Physiol; 1995 May; 268(5 Pt 2):H1862-8. PubMed ID: 7771537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adenosine agonists on consumptive behaviour and body temperature.
    Coupar IM; Tran BL
    J Pharm Pharmacol; 2002 Feb; 54(2):289-94. PubMed ID: 11858214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.
    Sandoli D; Chiu PJ; Chintala M; Dionisotti S; Ongini E
    Eur J Pharmacol; 1994 Jun; 259(1):43-9. PubMed ID: 7957592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
    De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
    Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.